Vergoeding 2020-2024 voor ATC-subgroep R03BB : Parasympathicolytica
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| R03BB01 Ipratropium (Atrovent ®) | 2.922.600 | 2.642.800 | 2.538.100 | 2.367.700 | 2.096.100 |
| R03BB04 Tiotropium (Spiriva ®) | 55.215.300 | 39.116.300 | 33.726.100 | 29.776.600 | 26.080.700 |
| R03BB05 Aclidiniumbromide (Eklira ®) | 1.191.500 | 1.099.600 | 1.058.700 | 1.039.700 | 992.330 |
| R03BB06 Glycopyrroniumbromide (Seebri breezhaler ®) | 1.574.100 | 1.219.700 | 1.125.200 | 960.270 | 815.920 |
| R03BB07 Umeclidiniumbromide (Incruse ellipta ®) | 774.360 | 1.963.200 | 2.001.200 | 1.968.500 | 1.907.600 |
| Totaal | 61.677.860 | 46.041.600 | 40.449.300 | 36.112.770 | 31.892.650 |